NCT01934647 Acute Dosing of MK-8892 in Participants With Pulmonary Arterial Hypertension (PAH) (MK-8892-003) Status TERMINATED Phase PHASE1
NCT01932762 Efficacy and Safety of Combination Grazoprevir (MK-5172) + Elbasvir (MK-8742) + Ribavirin (RBV) in Genotype 2 Hepatitis C Infection (MK-5172-047) Status COMPLETED Phase PHASE2
NCT01930058 Safety, Pharmacokinetics, and Pharmacodynamics of MK-8876 in Participants With Hepatitis C Infection (MK-8876-003) Status COMPLETED Phase PHASE1
NCT01930045 A Pharmacokinetic Study to Evaluate the Effect of MAALOX on Raltegravir (MK-0518) in Human Immunodeficiency Virus (HIV)-Infected Participants (MK-0518-295) Status COMPLETED Phase PHASE1
NCT01928511 Efficacy of Switching or Adding Pegylated Interferon in Chronic Hepatitis B Patients on Long Term Oral Antiviral Therapy Status COMPLETED Phase PHASE4
NCT01928225 Randomized, Double Blind Trial of the Quadrivalent HPV Vaccine to Improve Responses to LEEP Treatment of Cervical HSIL Status COMPLETED Phase PHASE2
NCT01928199 Efficacy Study of Sitagliptin to Prevent New-onset Diabetes After Kidney Transplant Status COMPLETED Phase PHASE4
NCT01926509 Study to Assess the Safety, Tolerability and Pharmacokinetics (PK) of MK-8892 in Participants With Pulmonary Arterial Hypertension (PAH) (MK-8892-005) Status COMPLETED Phase PHASE1
NCT01926015 Immunogenicity and Safety of Concomitant Administration of RotaTeq™ (V260) and the Diphtheria, Tetanus, Pertussis and Inactivated Poliovirus Vaccine (DTP-IPV) in Healthy Japanese Infants (V260-060) Status COMPLETED Phase PHASE4
NCT01926002 A Single-Dose Study of MK-8351 in a Lung Allergen Challenge (MK-8351-003) Status WITHDRAWN Phase PHASE1
NCT01919125 Pharmacokinetics of IDX719 in Participants With Normal and Impaired Hepatic Function (MK-1894-008) Status COMPLETED Phase PHASE1
NCT01916512 Relationship Between CETP Deficiency and Atherosclerosis in Patients With Hyperalphalipoproteinemia Status UNKNOWN Phase N/A
NCT01909401 Pilot Study With Peginterferon, Ribavirin, and Boceprevir Prior to Transplantation to Clear Virus in Hepatitis C Genotype 1 Infected Individuals Undergoing Orthotopic Liver Transplantation Status COMPLETED Phase EARLY_PHASE1
NCT01907724 Drug-Drug Interaction Between IDX719, Simeprevir, TMC647055 and Ritonavir When Administered in Combination in Healthy Participants (MK-1894-007) Status COMPLETED Phase PHASE1
NCT01905657 Study of Two Doses of Pembrolizumab (MK-3475) Versus Docetaxel in Previously Treated Participants With Non-Small Cell Lung Cancer (MK-3475-010/KEYNOTE-010) Status COMPLETED Phase PHASE2/PHASE3
NCT01879085 Study of Vorinostat in Combination With Gemcitabine and Docetaxel in Advanced Sarcoma Status COMPLETED Phase PHASE1/PHASE2
NCT01876511 Study of MK-3475 in Patients With Microsatellite Unstable (MSI) Tumors (Cohorts A, B and C) Status COMPLETED Phase PHASE2